Bin Wang

发表

Discovery of the first-in-class dual PPARδ/γ partial agonist for the treatment of metabolic syndrome.

Luyong Zhang, Jing Han, Zheng Li, 2021, European journal of medicinal chemistry.

Analysis of the prognostic role and biological characteristics of circulating tumor cell-associated white blood cell clusters in non-small cell lung cancer

Zheng Li, Xuelin Zhang, D. Tang, 2021, Journal of thoracic disease.

Discovery of new and highly effective quadruple FFA1 and PPARα/γ/δ agonists as potential anti-fatty liver agents.

Luyong Zhang, Zheng Li, Q. Ren, 2021, European journal of medicinal chemistry.

HWL‐088, a new and highly effective FFA1/PPARδ dual agonist, attenuates nonalcoholic steatohepatitis by regulating lipid metabolism, inflammation and fibrosis

Guangji Wang, Zheng Li, Q. Ren, 2020, The Journal of pharmacy and pharmacology.

Discovery of a structurally novel, potent, and once-weekly free fatty acid receptor 1 agonist for the treatment of diabetes.

Luyong Zhang, Zhongcheng Yang, Zheng Li, 2022, European journal of medicinal chemistry.

Graveoline Analogs Exhibiting Selective Acetylcholinesterase Inhibitory Activity as Potential Lead Compounds for the Treatment of Alzheimer’s Disease

Zeng Li, Juan Jin, Bin Wang, 2016, Molecules.

Quinazoline derivative compound (11d) as a novel angiogenesis inhibitor inhibiting VEGFR2 and blocking VEGFR2-mediated Akt/mTOR /p70s6k signaling pathway

Jun Li, Zeng Li, Liang Tang, 2016, Iranian journal of basic medical sciences.

Hepatoprotective effects of ZLY16, a dual peroxisome proliferator-activated receptor α/δ agonist, in rodent model of nonalcoholic steatohepatitis.

Luyong Zhang, Zheng Li, Q. Ren, 2020, European journal of pharmacology.

Discovery of the First-in-Class Intestinal Restricted FXR and FABP1 Dual Modulator ZLY28 for the Treatment of Nonalcoholic Fatty Liver Disease.

Luyong Zhang, Zhongcheng Yang, Zheng Li, 2023, Journal of medicinal chemistry.

Discovery of a novel and orally active Farnesoid X receptor agonist for the protection of acetaminophen‐induced hepatotoxicity

Guangji Wang, Zheng Li, Q. Ren, 2021, Chemical biology & drug design.

Design, synthesis, and biological studies of novel 3-benzamidobenzoic acid derivatives as farnesoid X receptor partial agonist.

Zheng Li, Q. Ren, Zongtao Zhou, 2020, European journal of medicinal chemistry.

Quinazoline derivative compound (11d) as a novel angiogenesis inhibitor inhibiting VEGFR2 and blocking VEGFR2-mediated Akt/mTOR /p70s6k signaling pathway

Jun Li, Zeng Li, Liang Tang, 2016, Iranian journal of basic medical sciences.